Advantage Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$45K Sell
405
-110
-21% -$12.2K 0.04% 358
2019
Q2
$57K Buy
515
+86
+20% +$10.1K 0.04% 316
2019
Q1
$56K Sell
429
-132
-24% -$16.1K 0.04% 322
2018
Q4
$65K Buy
561
+143
+34% +$16K 0.05% 299
2018
Q3
$45K Buy
418
+101
+32% +$10.1K 0.03% 408
2018
Q2
$27K Hold
317
0.02% 483
2018
Q1
$25K Sell
317
-50
-14% -$4.03K 0.01% 514
2017
Q4
$31K Hold
367
0.01% 493
2017
Q3
$31K Sell
367
-17
-4% -$1.39K 0.01% 484
2017
Q2
$32K Sell
384
-83
-18% -$6.77K 0.01% 479
2017
Q1
$39K Hold
467
0.02% 400
2016
Q4
$34K Sell
467
-587
-56% -$43.7K 0.01% 407
2016
Q3
$85K Sell
1,054
-558
-35% -$44.7K 0.03% 242
2016
Q2
$127K Buy
1,612
+83
+5% +$6.25K 0.06% 191
2016
Q1
$110K Buy
1,529
+100
+7% +$7.57K 0.05% 210
2015
Q4
$120K Buy
1,429
+1,134
+384% +$94.1K 0.06% 201
2015
Q3
$25K Sell
295
-1,469
-83% -$124K 0.01% 416
2015
Q2
$147K Buy
1,764
+275
+18% +$21K 0.07% 178
2015
Q1
$108K Buy
1,489
+31
+2% +$2.21K 0.06% 226
2014
Q4
$101K Buy
+1,458
New +$98.4K 0.08% 211

Other funds holding LLY

Advantage Investment Management's LLY Position: Q3 2019 in Review

Advantage Investment Management reduced its Eli Lilly (LLY) stake by 21% in Q3 2019, selling an estimated $12.2K and leaving 405 shares worth $45K. The position accounts for 0.04% of the portfolio, ranked #358.

Advantage Investment Management first reported a position in LLY in Q4 2014 and has held it in 20 quarters since. The position peaked at $147K in Q2 2015. 1,524 funds tracked by Wall St. Rank hold LLY as of Q3 2019.

  • Advantage Investment Management held 405 shares of Eli Lilly worth $45K as of Q3 2019.
  • Advantage Investment Management sold 110 Eli Lilly shares in Q3 2019, an estimated $12.2K.
  • Eli Lilly made up 0.04% of Advantage Investment Management's portfolio in Q3 2019, its #358 holding.
  • Advantage Investment Management first reported a position in Eli Lilly in Q4 2014 and has held it in 20 quarters since.
  • Advantage Investment Management's Eli Lilly position peaked at $147K in Q2 2015.
  • 1,524 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.